Market Cap (In USD)
721.23 Million
Revenue (In USD)
202.08 Million
Net Income (In USD)
-61.68 Million
Avg. Volume
1394.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7.121-15.38
- PE
- -
- EPS
- -
- Beta Value
- 1.315
- ISIN
- US30052C1071
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Mr. David Moatazedi
- Employee Count
- -
- Website
- https://www.evolus.com
- Ipo Date
- 2018-08-03
- Details
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
More Stocks
-
184AMANABI-AID CO LTD
184A
-
VH2
-
AACS
-
6613QD Laser, Inc.
6613
-
HLANHilan Ltd.
HLAN
-
ENETFEthernity Networks Ltd.
ENETF
-
CJTCargojet Inc.
CJT
-
6722